The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications.

Apelin is a recently discovered peptide, identified as an endogenous ligand of receptor APJ. Apelin and receptor APJ are expressed in a wide variety of tissues including heart, brain, kidneys and lungs. Their interaction may have relevant pathophysiologic effects in those tissues. In fact, the last decade has been rich in illustrating the possible roles played by apelin in human physiology, namely as a regulating peptide of cardiovascular, hypothalamus-hypophysis, gastrointestinal, and immune systems. The possible involvement of apelin in the pathogenesis of high prevalence conditions and comorbidities - such as hypertension, heart failure, and Diabetes Mellitus Type 2 (T2DM) - rank it as a likely therapeutic target to be investigated in the future. The present paper is an overview of apelin physiologic effects and presents the possible role played by this peptide in the pathogenesis of a number of conditions as well as the therapeutic implications that might, therefore, be investigated.

[1]  G. Greeley,et al.  Increased colonic apelin production in rodents with experimental colitis and in humans with IBD , 2007, Regulatory Peptides.

[2]  K. Higuchi,et al.  Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. , 2007, Endocrinology.

[3]  Yu Huang,et al.  Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. , 2007, Cardiovascular research.

[4]  E. Vanninen,et al.  Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy , 2007, Regulatory Peptides.

[5]  M. Volpe,et al.  Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin , 2007, European journal of heart failure.

[6]  S. Tang,et al.  Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways , 2007, Peptides.

[7]  W. Gao,et al.  Apelin increases contractility in failing cardiac muscle. , 2006, European journal of pharmacology.

[8]  L. van den Berghe,et al.  Therapeutic potential of interfering with apelin signalling. , 2006, Drug discovery today.

[9]  M. Berry,et al.  Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression , 2006, Cellular & Molecular Biology Letters.

[10]  Gangyi Yang,et al.  Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[11]  Y. Kihara,et al.  Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system. , 2006, Journal of molecular and cellular cardiology.

[12]  N. Rowland,et al.  Effects of central and peripheral injections of apelin on fluid intake and cardiovascular parameters in rats , 2006, Physiology & Behavior.

[13]  P. Ellinor,et al.  Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. , 2006, Journal of the American College of Cardiology.

[14]  Xian Wang,et al.  Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. , 2006, Life sciences.

[15]  I. Castan-Laurell,et al.  TNFα up‐regulates apelin expression in human and mouse adipose tissue , 2006 .

[16]  E. Ashley,et al.  Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure , 2006, European journal of heart failure.

[17]  A. Fukamizu,et al.  Apelin Stimulates Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[18]  J. Małyszko,et al.  Apelin and Cardiac Function in Hemodialyzed Patients: Possible Relations? , 2006, American Journal of Nephrology.

[19]  B. O'dowd,et al.  Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. , 2006, Trends in pharmacological sciences.

[20]  J. Penninger,et al.  Angiotensin-converting enzyme II in the heart and the kidney. , 2006, Circulation research.

[21]  B. Geng,et al.  Apelin protects myocardial injury induced by isoproterenol in rats , 2006, Regulatory Peptides.

[22]  J. Rehfeld,et al.  Apelin: A new plasma marker of cardiopulmonary disease , 2006, Regulatory Peptides.

[23]  B. Ahrén,et al.  The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice , 2005, Regulatory Peptides.

[24]  A. Leite-Moreira,et al.  Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. , 2005, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[25]  K. Herzig,et al.  Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding , 2005, Regulatory Peptides.

[26]  A. Davenport,et al.  Emerging roles of apelin in biology and medicine. , 2005, Pharmacology & therapeutics.

[27]  B. Masri,et al.  Apelin signalling: a promising pathway from cloning to pharmacology. , 2005, Cellular signalling.

[28]  I. Castan-Laurell,et al.  Apelin, a newly identified adipokine up-regulated by insulin and obesity. , 2005, Endocrinology.

[29]  J. Skepper,et al.  Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells , 2005, Regulatory Peptides.

[30]  M. Cornu,et al.  Apelin (65‐77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  M. Berry,et al.  Apelin Has In Vivo Inotropic Effects on Normal and Failing Hearts , 2004, Circulation.

[32]  A. Fukamizu,et al.  Regulatory Roles for APJ, a Seven-transmembrane Receptor Related to Angiotensin-type 1 Receptor in Blood Pressure in Vivo* , 2004, Journal of Biological Chemistry.

[33]  A. Davenport,et al.  Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells , 2004, Regulatory Peptides.

[34]  G. Greeley,et al.  Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. , 2004, Endocrinology.

[35]  B. O'dowd,et al.  Agonist-independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2 Receptors* , 2004, Journal of Biological Chemistry.

[36]  D. Sunter,et al.  Intracerebroventricular injection of apelin-13 reduces food intake in the rat , 2003, Neuroscience Letters.

[37]  F. Horkay,et al.  Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. , 2003, Biochemical and biophysical research communications.

[38]  M. Saint-Geniez,et al.  The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. , 2003, Gene expression patterns : GEP.

[39]  M. Morris,et al.  Inhibitory Effect of Apelin-12 on Nocturnal Food Intake in the Rat , 2003, Nutritional neuroscience.

[40]  Robert P. Davis,et al.  Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin , 2003, Journal of neurochemistry.

[41]  J. Rysä,et al.  Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility , 2002, Circulation research.

[42]  M. Palkovits,et al.  Distribution of apelin-synthesizing neurons in the adult rat brain , 2002, Neuroscience.

[43]  T. Parsons,et al.  Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase* , 2002, The Journal of Biological Chemistry.

[44]  S. Bloom,et al.  The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. , 2002, Biochemical and biophysical research communications.

[45]  H. Lahlou,et al.  Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. , 2002, Biochemical and biophysical research communications.

[46]  M. Fujimiya,et al.  The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism , 2001, Regulatory Peptides.

[47]  M. Palkovits,et al.  Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain , 2001, Journal of neurochemistry.

[48]  O. Nishimura,et al.  Molecular properties of apelin: tissue distribution and receptor binding. , 2001, Biochimica et biophysica acta.

[49]  A. Davenport,et al.  [125I]‐(Pyr1)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man , 2001, British journal of pharmacology.

[50]  J. Sodroski,et al.  Apelin, the Natural Ligand of the Orphan Seven-Transmembrane Receptor APJ, Inhibits Human Immunodeficiency Virus Type 1 Entry , 2000, Journal of Virology.

[51]  R. Doms,et al.  Expression and coreceptor function of APJ for primate immunodeficiency viruses. , 2000, Virology.

[52]  M. Palkovits,et al.  Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. , 2000, Biochimica et biophysica acta.

[53]  Hui-yu Liu,et al.  Apelin peptides block the entry of human immunodeficiency virus (HIV) , 2000, FEBS letters.

[54]  B. O'dowd,et al.  Characterization of Apelin, the Ligand for the APJ Receptor , 2000, Journal of neurochemistry.

[55]  S. Murosaki,et al.  Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. , 1999, Biochimica et biophysica acta.

[56]  P. Thiébaud,et al.  Two skeletal α-tropomyosin transcripts with distinct 3′UTR have different temporal and spatial patterns of expression in the striated muscle lineages of Xenopus laevis , 1999, Mechanisms of Development.

[57]  S. Hinuma,et al.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. , 1998, Biochemical and biophysical research communications.

[58]  R. Doms,et al.  An Orphan Seven-Transmembrane Domain Receptor Expressed Widely in the Brain Functions as a Coreceptor for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus , 1998, Journal of Virology.

[59]  Miriam K. Konkel,et al.  The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[60]  H. Heng,et al.  A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. , 1993, Gene.

[61]  C. Llorens-Cortes,et al.  Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release. , 2007, American journal of physiology. Endocrinology and metabolism.

[62]  I. Castan-Laurell,et al.  TNFalpha up-regulates apelin expression in human and mouse adipose tissue. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  H. Xie,et al.  Apelin suppresses apoptosis of human osteoblasts , 2006, Apoptosis.

[64]  P. Ellinor,et al.  Reduced apelin levels in lone atrial fibrillation. , 2006, European heart journal.

[65]  B. O'dowd,et al.  Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. , 2005, Endocrinology.

[66]  E. Ashley,et al.  The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. , 2005, Cardiovascular research.

[67]  L. Poellinger,et al.  The FASEB Journal • Research Communication Hypoxia inducible factor regulates the cardiac expression and secretion of apelin , 2022 .